As shown in Figure 2, the correlation analysis was performed between HER2 status before receiving treatment and some clinicopathological characteristics including tumor size, differentiation, lymph node metastasis, and distant metastasis. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.